DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Implantable Medical Devices Market (2016-2022)" report to their offering.
The term Implant is used for the devices that replace or support biological structure. Implantable medical devices or tissues are placed inside or on the surface of the body for the replacement of missing biological structure or are used to provide support to the biological structure. Some Implantable devices are made up of metal, plastic ceramic or other materials and some are made from skin, bones or other body tissues. These devices can be placed permanently or temporally and they help in monitoring and treating clinical disorders.
The key factors driving the growth of the market are growing incidences of cardiovascular diseases, technological advancements, growing acceptance of medical implants, improvement in healthcare infrastructure, and growth in the number of geriatric population. An increase in the proportion of the aged group is associated with an increase in the prevalence of ill health.
Due to increasing ill health among the older population, the need for new treatments, implantable medical devices and other medical procedures would grow. However, factors such as high cost of medical implants, reimbursement issues, and stringent regulatory policies for product approval are hampering the growth of the market.
- Abbott laboratories.
- Boston Scientific Corporation
- Conmed corporation
- Johnson & Johnson
- Medtronic plc
- Smith and Nephew Plc
- Stryker Corporation
- C.R. Bard, Inc.
- Cardinal health, Inc.
Globus medical, Inc.
Key Topics Covered:
1. Market Scope & Methodology
2. Executive Summary
3. Market Overview
4. Global Implantable Medical Devices Market by Material
5. Global Implantable Medical Devices Market by Product
6. Global Implantable Medical Devices Market by Country
7. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/kppcqw/global